Advanced search
Start date

Mechanisms of tumor resistance to cisplatin: DNA lesions processing and circadian cycle effect

Grant number: 17/24217-0
Support Opportunities:Scholarships in Brazil - Doctorate (Direct)
Effective date (Start): April 01, 2018
Effective date (End): August 31, 2022
Field of knowledge:Biological Sciences - Biochemistry - Molecular Biology
Principal Investigator:Carlos Frederico Martins Menck
Grantee:Matheus Molina Silva
Host Institution: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brazil
Associated research grant:14/15982-6 - Consequences of repair deficiencies in damaged genome, AP.TEM


Currently, Cancer is one of the main causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012 and 8.8 million Cancer-related deaths in 2015, in which 1.69 million were from Lung Cancer. This high index of mortality is mainly due to the shortage of treatments that provide a definitive cure, or even a longer life span. One of the most used treatments is the chemotherapy with cisplatin, based on the cytotoxicity caused by DNA damage induced by the drug. However, drug resistance is very common, due to alterations in the expression of genes that protect the cells. Among these alterations, the augmented expression of the proteins ERCC1 and XPF, components of the Nucleotide Excision Repair pathway (NER), and of the well-known master regulator of antioxidant response, the transcription factor NRF2, stand out as main causes of resistance in some cases. Some studies also show that the DNA polymerase eta, involved in translesion synthesis, may be important for the resistance to cisplatin. Interestingly, there is evidence that these processes are under control of the circadian clock, an internal timing mechanism, orchestrating variations in behavior, physiology and metabolism, according to daily changes in our environment such as temperature and light/dark cycles. Thus, this project aims to understand the role of each process mentioned above in the establishment of cisplatin resistance in Lung Cancer cells, how they interact and their effects. Furthermore, we want to understand how the circadian clock influences each of these processes and can be an important factor in the resistance to the treatment with cisplatin. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications (4)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SILVA, MATHEUS MOLINA; REILY ROCHA, CLARISSA RIBEIRO; KINKER, GABRIELA SARTI; PELEGRINI, ALESSANDRA LUIZA; MARTINS MENCK, CARLOS FREDERICO. The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells. SCIENTIFIC REPORTS, v. 9, . (14/15982-6, 15/15184-5, 13/08028-1, 17/24217-0)
MONTEIRO DE ASSIS, LEONARDO VINICIUS; MENDES, DAVI; SILVA, MATHEUS MOLINA; KINKER, GABRIELA SARTI; PEREIRA-LIMA, ISABELLA; MORAES, MARIA NATHALIA; MARTINS MENCK, CARLOS FREDERICO; DE LAURO CASTRUCCI, ANA MARIA. Melanopsin mediates UVA-dependent modulation of proliferation, pigmentation, apoptosis, and molecular clock in normal and malignant melanocytes. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, v. 1867, n. 10, . (14/27287-0, 19/19435-3, 13/24337-4, 17/24615-5, 12/50214-4, 18/16511-8, 17/26651-9, 17/18781-0, 18/14728-0, 17/24217-0)
DE ASSIS, LEONARDO VINICIUS MONTEIRO; MORAES, MARIA NATHALIA; MENDES, DAVI; SILVA, MATHEUS MOLINA; MENCK, CARLOS FREDERICO MARTINS; CASTRUCCI, ANA MARIA DE LAURO. Loss of Melanopsin (OPN4) Leads to a Faster Cell Cycle Progression and Growth in Murine Melanocytes. CURRENT ISSUES IN MOLECULAR BIOLOGY, v. 43, n. 3, p. 1436-1450, . (18/16511-8, 17/24615-5, 17/26651-9, 17/18781-0, 19/19435-3, 18/14728-0, 17/24217-0)
MONTEIRO DE ASSIS, LEONARDO VINICIUS; LACERDA, JOSE THALLES; MORAES, MARIA NATHALIA; DOMINGUEZ-AMOROCHO, OMAR ALBERTO; KINKER, GABRIELA SARTI; MENDES, DAVI; SILVA, MATHEUS MOLINA; MARTINS MENCK, CARLOS FREDERICO; SARAIVA CAMARA, NIELS OLSEN; DE LAURO CASTRUCCI, ANA MARIA. Melanopsin (Opn4) is an oncogene in cutaneous melanoma. COMMUNICATIONS BIOLOGY, v. 5, n. 1, p. 15-pg., . (19/19435-3, 19/25129-2, 17/24217-0, 17/26651-9, 18/16511-8, 12/50214-4, 18/14728-0, 17/24615-5, 17/18781-0, 20/04524-8, 13/24337-4, 17/16711-4)

Please report errors in scientific publications list using this form.